Schedule
Stirling Ballroom
Time Speaker Topic
10:00 a. m.
Representative Adam Anderson( R-Palm Harbor) Alma Littles, M. D., Dean, FSU College of Medicine Pradeep Bhide, Ph. D., Director, IPRD
Keynote
Welcome & Introductory Remarks
10:10 a. m. David Bick, M. D., Ph. D., Genomics England, UK
Screening 100,000 Newborns Using Whole Genome Sequencing: Early Results of Genomics England’ s Generation Study
Session 1: Genomic Newborn Screening. Moderated by David Ledbetter
11:00 a. m. Katherine Stueland, President & CEO of GeneDx The Cost of Underdiagnosis
11:15 a. m. Moran Snir, CEO of Nest Genomics
The Future Starts at Birth: Operationalizing Newborn Genome Sequencing Programs with Nest
11:30 a. m.
11:45 a. m.
Tom DeFay, Deputy Head Diagnostics Strategy & Development, Alexion Pharmaceuticals
Ankit Malhotra, Global Head of Genomics, Amazon Web Services
BeginNGS, progress update, Healthcare implementation, and collaboration across consortia
Revolutionizing Pediatric Health Research: Data and AI-driven Innovation on AWS at Population Scale
12:00 p. m. Q & A
Lunch and Sunshine Genetics Program Update
12:30 p. m. Lunch and Updates from Partner Organizations, Patient Advocacy Groups, and Participating Families
1:00 p. m.
Sunshine Genetics Board of Overseers and Steering Committee Meeting, Program Updates and Open Discussion
Session 2: Advances in Gene Therapy. Moderated by Pradeep Bhide
2:30 p. m.
2:50 p. m.
3:10 p. m.
Miguel Sena-Esteves, Associate Professor, Department of Genetic and Cellular Medicine, UMass Chan Medical School
Boris Kantor, Director, Viral Vector and Gene Editing Core, IPRD
Barry Bryne, Director, Powell Gene Therapy Center, University of Florida, Gainesville
An alternative pathway for academia-led development of AAV gene therapies for ultra-rare diseases
Gene Therapy for Pediatric Rare Diseases: Current Status and Future Perspectives
Molecular Medicine and Advanced Therapeutics: Where are we now and vision for the next 10 years
3:30 p. m. Q & A
05